Our research lies at the interface of chemistry, biochemistry and translational molecular medicine. Molecular imaging goals focus on advancing positron-emission tomography/magnetic resonance imaging (PET/MRI) probes to image oncogenic signalling pathways in cancer. Research is funded by the European Research Council (ERC).
The appointed post-doc should have a background in synthetic chemistry and will conduct experimental research on all aspects of radiotracer development. Specific areas include: organic and inorganic synthesis, radiochemistry, nanoparticle chemistry, bioconjugation chemistry, cellular-based assays and PET imaging in vivo using animal models of human cancer.
Candidates must hold a Master’s (MSc or equivalent) degree and a PhD (or equivalent) in chemistry. Successful candidates will be ambitious, creative, and highly motivated, with an outstanding record of academic achievement. Essential requirements are:
Furthermore, ideal candidates will have extensive knowledge and experience in organic synthesis. Prior experience with photochemistry, nanoparticle chemistry and/or radiochemistry is an advantage.